Literature DB >> 11672514

Adverse events in peripheral progenitor cell collection: a 7-year experience.

R Moog1.   

Abstract

Collection of peripheral progenitor cells (PPC) by apheresis machines is generally regarded as a safe procedure. However, data about adverse events in PPC harvesting are scarce. In a monocentric retrospective study, the data of 540 PPC collections in a period of 7 years were reviewed. Adverse events were subdivided in collection-associated technical problems and patient/donor-related side effects. Patient/donor-related side effects occurred most often (19.8%); most of them were paresthesias due to citrate toxicity. Paresthesias were treated by oral (20.4%) or intravenous (1.1%) calcium supplementation. Problems with venous access were also seen frequently, resulting in blood flow alarms (11.3%) and blockades in the return line (4.3%). A total of 6.9% of these problems were catheter associated, requiring revision of the central venous line in 2.6%. Technical problems with the blood cell separators were observed in 11.7%. Ten PPC collections were discontinued due to adverse events. The data of this retrospective, monocentric analysis show that patient/donor-associated problems were observed in every fifth PPC harvest. Most of them were paresthesias, which could be easily treated by calcium supplementation. Problems with venous access and technical problems with the cell separators occurred in every tenth PPC collection.

Entities:  

Mesh:

Year:  2001        PMID: 11672514     DOI: 10.1089/152581601753193896

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  2 in total

Review 1.  Anticoagulation techniques in apheresis: from heparin to citrate and beyond.

Authors:  Grace Lee; Gowthami M Arepally
Journal:  J Clin Apher       Date:  2012-04-24       Impact factor: 2.821

2.  Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection.

Authors:  Maria Sassi; Paolo Dell'Anna; Gino Bernuzzi; Daniela Adorni; Francesco Fagnoni; Alberto Cepparulo; Angelo Eterno; Monica Barilli; Monica Ampollini; Alessandro Formentini; Massimo Franchini
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.